These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
57 related items for PubMed ID: 7772752
1. Hypocholesterolemic effect of exogenous dehydroepiandrosterone administration in the rhesus monkey. Haffa AL, MacEwen EG, Kurzman ID, Kemnitz JW. In Vivo; 1994; 8(6):993-7. PubMed ID: 7772752 [Abstract] [Full Text] [Related]
2. The effect of high fat diet and dehydroepiandrosterone (DHEA) administration in the rhesus monkey. Christopher-Hennings J, Kurzman ID, Haffa AL, Kemnitz JW, Macewen EG. In Vivo; 1995; 9(5):415-20. PubMed ID: 8900917 [Abstract] [Full Text] [Related]
3. Short-term dehydroepiandrosterone treatment increases platelet cGMP production in elderly male subjects. Martina V, Benso A, Gigliardi VR, Masha A, Origlia C, Granata R, Ghigo E. Clin Endocrinol (Oxf); 2006 Mar; 64(3):260-4. PubMed ID: 16487434 [Abstract] [Full Text] [Related]
4. Metabolic effects of 12-month percutaneous dehydroepiandrosterone replacement therapy in postmenopausal women. Diamond P, Cusan L, Gomez JL, Bélanger A, Labrie F. J Endocrinol; 1996 Sep; 150 Suppl():S43-50. PubMed ID: 8943786 [Abstract] [Full Text] [Related]
5. Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia. Mackness MI, Bhatnagar D, Durrington PN, Prais H, Haynes B, Morgan J, Borthwick L. Eur J Clin Nutr; 1994 Dec; 48(12):859-65. PubMed ID: 7889894 [Abstract] [Full Text] [Related]
6. HMR 3339, a novel selective estrogen receptor modulator, reduces total cholesterol, low-density lipoprotein cholesterol, and homocysteine in healthy postmenopausal women. Vogelvang TE, Mijatovic V, Kenemans P, Teerlink T, van der Mooren MJ. Fertil Steril; 2004 Dec; 82(6):1540-9. PubMed ID: 15589857 [Abstract] [Full Text] [Related]
7. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome. Yilmaz M, Biri A, Bukan N, Karakoç A, Sancak B, Törüner F, Paşaoğlu H. Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370 [Abstract] [Full Text] [Related]
8. Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men. Nestler JE, Barlascini CO, Clore JN, Blackard WG. J Clin Endocrinol Metab; 1988 Jan; 66(1):57-61. PubMed ID: 2961787 [Abstract] [Full Text] [Related]
9. Replacement of carbohydrate by protein in a conventional-fat diet reduces cholesterol and triglyceride concentrations in healthy normolipidemic subjects. Wolfe BM, Piché LA. Clin Invest Med; 1999 Aug; 22(4):140-8. PubMed ID: 10497712 [Abstract] [Full Text] [Related]
10. Effects of dehydroepiandrosterone supplement on health-related quality of life in glucocorticoid treated female patients with systemic lupus erythematosus. Nordmark G, Bengtsson C, Larsson A, Karlsson FA, Sturfelt G, Rönnblom L. Autoimmunity; 2005 Nov; 38(7):531-40. PubMed ID: 16373258 [Abstract] [Full Text] [Related]
11. Influence of cholesterol-lowering on plasma membrane lipids and function. Lijnen P, Echevaría-Vázquez D, Petrov V. Methods Find Exp Clin Pharmacol; 1996 Mar; 18(2):123-36. PubMed ID: 8740244 [Abstract] [Full Text] [Related]
12. Soy protein reduces the arterial low-density lipoprotein (LDL) concentration and delivery of LDL cholesterol to the arteries of diabetic and nondiabetic male cynomolgus monkeys. Wagner JD, Zhang L, Greaves KA, Shadoan MK, Schwenke DC. Metabolism; 2000 Sep; 49(9):1188-96. PubMed ID: 11016902 [Abstract] [Full Text] [Related]
13. The effect of dehydroepiandrosterone combined with a low-fat diet in spontaneously obese dogs: a clinical trial. Kurzman ID, Panciera DL, Miller JB, MacEwen EG. Obes Res; 1998 Jan; 6(1):20-8. PubMed ID: 9526966 [Abstract] [Full Text] [Related]
14. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice. Marsman D. Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194 [Abstract] [Full Text] [Related]
15. Increased binding of LDL and VLDL to apo B,E receptors of hepatic plasma membrane of rats treated with Fibernat. Venkatesan N, Devaraj SN, Devaraj H. Eur J Nutr; 2003 Oct; 42(5):262-71. PubMed ID: 14569407 [Abstract] [Full Text] [Related]
16. A novel peroxisome proliferator--activated receptor alpha/gamma dual agonist ameliorates dyslipidemia and insulin resistance in prediabetic rhesus monkeys. Ding SY, Tigno XT, Braileanu GT, Ito K, Hansen BC. Metabolism; 2007 Oct; 56(10):1334-9. PubMed ID: 17884441 [Abstract] [Full Text] [Related]
17. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program . Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928 [Abstract] [Full Text] [Related]
18. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial. Pearson T, Denke M, McBride P, Battisti WP, Brady WE, Palmisano J. Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317 [Abstract] [Full Text] [Related]
19. Effect of prolonged fasting on plasma lipids, lipoproteins and apolipoprotein B in 12 physicians participating in a hunger strike: an observational study. Fainaru M, Schafer Z. Isr Med Assoc J; 2000 Mar; 2(3):215-9. PubMed ID: 10774270 [Abstract] [Full Text] [Related]
20. Reduction in body weight and cholesterol in spontaneously obese dogs by dehydroepiandrosterone. Kurzman ID, MacEwen EG, Haffa AL. Int J Obes; 1990 Feb; 14(2):95-104. PubMed ID: 2140342 [Abstract] [Full Text] [Related] Page: [Next] [New Search]